News & Views

BRAIN Biotech AG publishes its Annual Report and reports record figures in fiscal year 2021/22

Letter from the Executive Board at the end of the year

Michael Schneiders took over as Chief Financial Officer (CFO) of BRAIN Biotech AG on October 1, 2022.

BRAIN Biotech AG published in mid-June its first sustainability report and initial ESG data. We asked our colleague Michael Schneiders, Head of IR and Sustainability, about the background, challenges and next steps in sustainability at BRAIN.

BRAIN has acquired Breatec B.V. including the Comix business to further enhance the growth trajectory of BRAIN’s BioIndustrial division and expand its enzyme portfolio to adjacent market segments.

On January 17 BRAIN Biotech AG has published its Annual Report including the detailed consolidated financial statements for the fiscal year 2020/21.